1. Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nature reviews Microbiology. 2015;13(5):269-84.
2. Lee SWH, Chan EMC, Lai YK. The global burden of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A systematic review and meta-analysis. Scientific reports. 2017;7(1):7984.
3. Yang Y, Deng Y, Wang Y. Major geogenic factors controlling geographical clustering of urolithiasis in China. The Science of the total environment. 2016;571:1164-71.
4. Sánchez-Martín FM, Millán Rodríguez F, Esquena Fernández S, Segarra Tomás J, Rousaud Barón F, Martínez-Rodríguez R, et al. [Incidence and prevalence of published studies about urolithiasis in Spain. A review]. Actas urologicas espanolas. 2007;31(5):511-20.
5. Lee MC, Bariol SV. Changes in upper urinary tract stone composition in Australia over the past 30 years. BJU international. 2013;112 Suppl 2:65-8.
6. Ghani KR, Roghmann F, Sammon JD, Trudeau V, Sukumar S, Rahbar H, et al. Emergency department visits in the United States for upper urinary tract stones: trends in hospitalization and charges. The Journal of urology. 2014;191(1):90-6.
7. Raheem OA, Khandwala YS, Sur RL, Ghani KR, Denstedt JD. Burden of Urolithiasis: Trends in Prevalence, Treatments, and Costs. European urology focus. 2017;3(1):18-26.
8. Global burden of 369 diseases and injuries in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet (London, England). 2020;396(10258):1204-22.
9. Hankey BF, Ries LA, Kosary CL, Feuer EJ, Merrill RM, Clegg LX, et al. Partitioning linear trends in age-adjusted rates. Cancer causes & control : CCC. 2000;11(1):31-5.
10. Hsueh PR, Hoban DJ, Carmeli Y, Chen SY, Desikan S, Alejandria M, et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. The Journal of infection. 2011;63(2):114-23.
11. Lu PL, Liu YC, Toh HS, Lee YL, Liu YM, Ho CM, et al. Epidemiology and antimicrobial susceptibility profiles of Gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009-2010 results from the Study for Monitoring Antimicrobial Resistance Trends (SMART). International journal of antimicrobial agents. 2012;40 Suppl:S37-43.
12. Gharbi M, Drysdale JH, Lishman H, Goudie R, Molokhia M, Johnson AP, et al. Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study. BMJ (Clinical research ed). 2019;364.
13. Gharbi M, Drysdale JH, Lishman H, Goudie R, Molokhia M, Johnson AP, et al. Antibiotic management of urinary tract infection in elderly patients in primary care and its association with bloodstream infections and all cause mortality: population based cohort study. BMJ (Clinical research ed). 2019;364:l525.
14. Chant C, Smith OM, Marshall JC, Friedrich JO. Relationship of catheter-associated urinary tract infection to mortality and length of stay in critically ill patients: a systematic review and meta-analysis of observational studies. Critical care medicine. 2011;39(5):1167-73.
15. Brun-Buisson C, Meshaka P, Pinton P, Vallet B. EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units. Intensive Care Med. 2004;30(4):580-8.
16. Veneziano D, Ploumidis A, Proietti S, Tokas T, Kamphuis G, Tripepi G, et al. Evolution and Uptake of the Endoscopic Stone Treatment Step 1 (EST-s1) Protocol: Establishment, Validation, and Assessment in a Collaboration by the European School of Urology and the Uro-Technology and Urolithiasis Sections. European urology. 2018;74(3):401-2.
17. Dhondup T, Kittanamongkolchai W, Vaughan LE, Mehta RA, Chhina JK, Enders FT, et al. Risk of ESRD and Mortality in Kidney and Bladder Stone Formers. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2018;72(6):790-7.
18. Speakman M, Kirby R, Doyle S, Ioannou C. Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK. BJU international. 2015;115(4):508-19.
19. Launer BM, McVary KT, Ricke WA, Lloyd GL. The rising worldwide impact of benign prostatic hyperplasia. BJU international. 2020.
20. Sidjabat HE, Paterson DL. Multidrug-resistant Escherichia coli in Asia: epidemiology and management. Expert review of anti-infective therapy. 2015;13(5):575-91.
21. Choe HS, Lee SJ, Cho YH, Çek M, Tandoğdu Z, Wagenlehner F, et al. Aspects of urinary tract infections and antimicrobial resistance in hospitalized urology patients in Asia: 10-Year results of the Global Prevalence Study of Infections in Urology (GPIU). Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy. 2018;24(4):278-83.
22. Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited. International journal of antimicrobial agents. 2012;39(1):45-51.
23. Tandogdu Z, Kakariadis ETA, Naber K, Wagenlehner F, Bjerklund Johansen TE. Appropriate empiric antibiotic choices in health care associated urinary tract infections in urology departments in Europe from 2006 to 2015: A Bayesian analytical approach applied in a surveillance study. PloS one. 2019;14(4):e0214710.
24. Howard P, Pulcini C, Levy Hara G, West RM, Gould IM, Harbarth S, et al. An international cross-sectional survey of antimicrobial stewardship programmes in hospitals. The Journal of antimicrobial chemotherapy. 2015;70(4):1245-55.
25. Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infectious disease clinics of North America. 2003;17(2):227-41.
26. Dielubanza EJ, Schaeffer AJ. Urinary tract infections in women. The Medical clinics of North America. 2011;95(1):27-41.
27. Gupta K, Grigoryan L, Trautner B. Urinary Tract Infection. Annals of internal medicine. 2017;167(7):Itc49-itc64.
28. Hooton TM. Pathogenesis of urinary tract infections: an update. The Journal of antimicrobial chemotherapy. 2000;46 Suppl 1:1-7; discussion 63-5.
29. Walker V, Stansbridge EM, Griffin DG. Demography and biochemistry of 2800 patients from a renal stones clinic. Annals of clinical biochemistry. 2013;50(Pt 2):127-39.
30. Lieske JC, Peña de la Vega LS, Slezak JM, Bergstralh EJ, Leibson CL, Ho KL, et al. Renal stone epidemiology in Rochester, Minnesota: an update. Kidney international. 2006;69(4):760-4.
31. Sorokin I, Mamoulakis C, Miyazawa K, Rodgers A, Talati J, Lotan Y. Epidemiology of stone disease across the world. World journal of urology. 2017;35(9):1301-20.
32. Scales CD, Jr., Tasian GE, Schwaderer AL, Goldfarb DS, Star RA, Kirkali Z. Urinary Stone Disease: Advancing Knowledge, Patient Care, and Population Health. Clinical journal of the American Society of Nephrology : CJASN. 2016;11(7):1305-12.
33. Egan KB. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates. The Urologic clinics of North America. 2016;43(3):289-97.